We work with mid-size CROs managing Phase II-III oncology and rare disease trials. If you want to see how the two-pass screening model applies to your specific protocol and EHR environment, reach out — we do our own demos.
We use essential cookies to keep this site secure and functional. We do not sell your data, run ad-tech, or share across sites. Optional analytics cookies help us improve the product — you can opt out anytime. Read our cookie policy.